Neurones S.A.

ENXTPA:NRO Lagerbericht

Marktkapitalisierung: €1.1b

Neurones Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Luc de Chammard

Geschäftsführender

€260.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts100.0%
Amtszeit als Geschäftsführer39.8yrs
Eigentum des Geschäftsführers59.6%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder19.9yrs

Jüngste Management Updates

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02
What We Learned About Neurones' (EPA:NRO) CEO Pay

Recent updates

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Jul 27
What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Apr 26
Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Dec 01
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

May 18
If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones' (EPA:NRO) Returns Have Hit A Wall

Feb 10
Neurones' (EPA:NRO) Returns Have Hit A Wall

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Oct 26
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Sep 22
Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Apr 28
Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Jan 25
Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Jan 06
Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Jul 20
Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

May 06
Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Mar 24
Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09
Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 16
The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Jan 25
Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Jan 11
What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Dec 28
Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Dec 15
Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02
What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Nov 17
Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Jun 30
Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Luc de Chammard im Vergleich zu den Einnahmen von Neurones verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

€48m

Mar 31 2024n/an/a

€49m

Dec 31 2023€260k€260k

€49m

Sep 30 2023n/an/a

€49m

Jun 30 2023n/an/a

€48m

Mar 31 2023n/an/a

€46m

Dec 31 2022€240k€240k

€44m

Sep 30 2022n/an/a

€43m

Jun 30 2022n/an/a

€41m

Mar 31 2022n/an/a

€40m

Dec 31 2021€220k€220k

€38m

Sep 30 2021n/an/a

€37m

Jun 30 2021n/an/a

€36m

Mar 31 2021n/an/a

€33m

Dec 31 2020€220k€220k

€31m

Sep 30 2020n/an/a

€30m

Jun 30 2020n/an/a

€28m

Mar 31 2020n/an/a

€30m

Dec 31 2019€220k€220k

€31m

Sep 30 2019n/an/a

€30m

Jun 30 2019n/an/a

€30m

Mar 31 2019n/an/a

€28m

Dec 31 2018€220k€220k

€26m

Sep 30 2018n/an/a

€26m

Jun 30 2018n/an/a

€26m

Mar 31 2018n/an/a

€27m

Dec 31 2017€200k€200k

€27m

Vergütung im Vergleich zum Markt: LucDie Gesamtvergütung ($USD289.98K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt French ($USD970.35K).

Entschädigung vs. Einkommen: LucDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Luc de Chammard (70 yo)

39.8yrs

Amtszeit

€260,000

Vergütung

Mr. Luc de Chammard serves as the Chairman, Chief Executive Officer and Chief Information Officer of Neurones S.A. and served as its Co-Chief Executive Officer. Mr. de Chammard has been a Director at Neuro...

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Luc de Chammard
Chairman39.8yrs€260.00k59.58%
€ 633.4m
Bertrand Ducurtil
COO, Executive VP25.3yrs€260.00k4.15%
€ 44.1m
Hervé Pichard
Director19.9yrs€5.00k0.00041%
€ 4.4k
Jean-Louis Pacquement
Independent Director39.8yrs€5.00k0.000020%
€ 212.6
Marie-Françoise Jaubert
Independent Director13.3yrs€4.00k0.00018%
€ 1.9k
Daphné de Chammard
Director8.3yrs€4.00k0.025%
€ 266.9k
Emmanuelle Canza
Employee Representative Director5.3yrskeine Datenkeine Daten

19.9yrs

Durchschnittliche Betriebszugehörigkeit

69.5yo

Durchschnittliches Alter

Erfahrener Vorstand: NRODie Vorstandsmitglieder sind sehr erfahren ( 19.8 ).